Prevalence of anemia and effects on mortality in patients with heart failure.
about
Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questionsClinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fractionRed blood cell transfusion in the critically ill patient.Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.Need for quality improvement in renal systematic reviews.Emerging drugs for acute and chronic heart failure: current and future developments.Anemia does not predict mortality in elderly patients with heart failure.Chronic kidney disease, heart failure and anemiaThe correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.The role of correction of anaemia in patients with congestive heart failure: a short review.Hemoglobin and overt nephropathy complications in type 1 diabetes.Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.Pediatric Heart Failure, Lagging, and Sagging of Care in Low Income Settings: A Hospital Based Review of Cases in Ethiopia.Noncardiac comorbidities and acute heart failure patients.Animal models of cardiorenal syndrome: a review.Iron deficiency anemia in heart failure.Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?The effects of anaemia and transfusion on patients with traumatic brain injury: A review.Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients.Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis.Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support.Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure
P2860
Q24651385-CB875502-A660-46F1-B7A0-132B491F0618Q34021375-014741D4-1106-4159-95DA-B5B082E0CEFBQ34065957-A1DC9492-B2C4-4A34-9AD3-A4A0262AF310Q34118880-16AE9887-58D2-4AD4-9091-B4A14FAB070EQ34625223-196D0CF5-15AF-47BC-B501-D81260ADED78Q35520728-E0A6A2F2-CF95-46DF-95CA-66AE79E99AF6Q36616210-D553D216-7F59-43C4-9520-08536F8B6D50Q36736617-5EFCC954-0869-4DF1-B7DE-8AF5928C190AQ36758585-BDB200F1-C0CC-4237-AA4F-4615B9560051Q36767728-D1CCA424-2063-4CBA-A645-3DD6C399B98BQ37217352-74D46C34-F417-415D-9B20-D29AFE134414Q37231779-BA8A8554-3BB4-409C-9861-80E779E0508EQ37243581-F49FF26F-94CF-4B34-B5A2-EB966978EC6CQ37253710-341559FA-2F1E-4DDC-8007-CD55256B659DQ37276822-38A9A008-F0B6-43CB-BD91-11CF3C045B8CQ37453497-93A1D6A4-57AE-47A1-911D-4A9742FB5FCCQ37531314-501978E2-54C2-412D-99AB-369313E26C80Q37930478-EE3A9711-09E0-4357-9E81-797DFA37512FQ38040656-145D3A35-B404-489C-B3ED-D60E7242D232Q38905476-A6216265-5572-40A2-9A32-9481D51984A1Q38966784-64AE529A-5B2B-4DE2-84A8-7D441D26F90EQ39977624-B88D61B0-484B-4E37-B5BE-38E88B41F119Q41016380-5F45C4FB-2428-448F-98F3-F0FE48225E4AQ42251217-4BCEF0C4-FD14-4660-B4A7-1A6A91963083Q43269512-F92C819B-7297-4315-A263-3251FBEB28B8Q43773570-09822F91-7C21-48D0-A63F-8C04ED799FBDQ51577468-21ED2C0D-8BE1-4726-AEEF-2E285A44B2B7Q57422687-746AE28D-9709-4EC7-88DD-C020BD9E8BE6
P2860
Prevalence of anemia and effects on mortality in patients with heart failure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prevalence of anemia and effects on mortality in patients with heart failure.
@ast
Prevalence of anemia and effects on mortality in patients with heart failure.
@en
type
label
Prevalence of anemia and effects on mortality in patients with heart failure.
@ast
Prevalence of anemia and effects on mortality in patients with heart failure.
@en
prefLabel
Prevalence of anemia and effects on mortality in patients with heart failure.
@ast
Prevalence of anemia and effects on mortality in patients with heart failure.
@en
P1476
Prevalence of anemia and effects on mortality in patients with heart failure.
@en
P2093
Joann Lindenfeld
P304
P356
10.1016/J.AHJ.2004.08.039
P407
P577
2005-03-01T00:00:00Z